Add BrightSurf on Google Email

Biomimetic nanoparticle combines antibacterial and regenerative actions for periodontitis

11.08.26 | West China Hospital of Sichuan University

A biomimetic nanoparticle that combines antibacterial, immunomodulatory, and regenerative actions could offer a more comprehensive strategy for periodontitis. Researchers developed neutrophil–macrophage hybrid membrane-coated minocycline-loaded gelatin nanoparticles (NMm@MINO) and evaluated whether the platform could control periodontal pathogens, reprogram macrophages toward a repair-associated phenotype, and support periodontal tissue repair. The nanoparticle was designed for protease-responsive drug release and tested for bactericidal activity in vitro, macrophage polarization, osteogenesis, osteoclastogenesis, fibroblast function, as well as its therapeutic effects in a ligature-induced rat model. The work supports a multi-target local therapeutic approach that addresses infection, inflammation, and tissue destruction together rather than focusing on bacterial control alone.

Periodontitis is a chronic inflammatory disease driven by pathogenic microbial communities and an unbalanced host immune response, leading to progressive destruction of periodontal soft and hard tissues. Porphyromonas gingivalis ( P. gingivalis ) is a key pathogen that can degrade gingival collagen and evade host defenses. Conventional scaling and root planing (SRP) primarily targets subgingival biofilm and calculus, while additional therapeutic strategies may be needed to address persistent inflammation and promote periodontal tissue regeneration. Local nanoparticle delivery can improve drug retention, yet rapid immune clearance, limited penetration into periodontal pockets, and insufficient active targeting remain barriers. Given these challenges, in-depth research is needed on integrated local nanoplatforms that can simultaneously control infection, restore immune homeostasis, and promote periodontal regeneration.

The study, published (DOI: 10.1038/s41368-026-00459-y) on 26 October 2026 in International Journal of Oral Science , involved researchers at Chongqing Medical University and collaborators; animal experiments were approved by the Animal Ethics Committee at Chongqing Medical University. The team developed neutrophil–macrophage hybrid membrane-coated minocycline-loaded gelatin nanoparticles (NMm@MINO) and evaluated its physicochemical properties, biosafety, antibacterial and immunomodulatory effects in vitro, and therapeutic efficacy in a rat ligature-induced periodontitis model at early, intermediate, and advanced disease stages. The work combined materials characterization with macrophage, osteoblast, osteoclast, and fibroblast assays before in vivo testing.

NMm@MINO formed a stable core–shell structure, with a hybrid membrane shell surrounding a minocycline-loaded gelatin core. The gelatin core was designed to release minocycline in response to elevated gelatinase activity in inflamed periodontal tissue. In vitro, the platform showed strong bactericidal activity against P. gingivalis and Staphylococcus aureus ( S. aureus ). In macrophages, NMm@MINO downregulated M1-associated transcripts ( Nos2 , Tnf , Il1b , and Cd86 ) and upregulated M2-associated markers ( Mrc1 , Arg1 , and Tgfβ1 ), consistent with decreased inducible nitric oxide synthase (iNOS) and increased cluster of differentiation 206 (CD206) immunofluorescence. It enhanced osteogenic markers ( Alpl , Spp1 , and Runx2 ), suppressed receptor activator of nuclear factor-κB ligand (RANKL)-induced osteoclastogenesis, reduced tartrate-resistant acid phosphatase (TRAP) staining, and lowered osteoclast-related genes ( Acp5 , Tnfsf11 , Ctsk , Fos , and Mmp9 ). It also promoted fibroblast migration and collagen I expression. In vivo, local NMm@MINO reduced interleukin-6 (IL-6) and C-reactive protein (CRP), improved collagen remodeling, and mitigated alveolar bone loss while modulating TRAP and the RANKL/osteoprotegerin (OPG) axis. The authors highlighted the combination of gelatinase-responsive minocycline release, cytokine-neutralizing activity of the hybrid membrane observed in vitro, and beneficial effects on bone and soft-tissue cells as the platform’s distinguishing features.

The authors said the design was intended to move beyond bacterial killing alone. The hybrid membrane was designed to facilitate interactions with inflamed periodontal tissues, while the gelatin core enables gelatinase-responsive minocycline release. NMm@MINO integrates local minocycline delivery, membrane-associated immunomodulatory activity, and pro-regenerative effects. Across the evaluated experimental models, the combined formulation generally showed greater therapeutic benefits than free minocycline or hybrid membrane vesicles alone. They said future work should investigate periodontal pocket retention, biodistribution, potential effects on the oral microbiome, and manufacturing scalability.

The findings support further investigation of NMm@MINO as a local adjunct to scaling and root planing (SRP) or local drug delivery (LDD) approaches for periodontitis, particularly for addressing the interconnected processes of infection, inflammation, and tissue destruction. A local injectable system may improve drug retention at periodontal sites while potentially reducing the need for systemic antibiotic administration. Questions remain, including antibiotic-resistance risk, effects on the oral microbiome, manufacturing consistency for cell membrane-based materials, storage stability, and further quantitative evaluation of periodontal pocket retention and active targeting. Head-to-head studies with established clinical LDD products and tracking/biodistribution studies will be needed before clinical translation. If validated, the platform could inform next-generation biomimetic therapies for other inflammatory diseases.

###

References

DOI

10.1038/s41368-026-00459-y

Original Source URL

https://doi.org/10.1038/s41368-026-00459-y

Funding i nformation

This work was supported by grants from the National Natural Science Foundation of China (Nos. 82571134, 82370996, 82170997 and 32200768), Sichuan Science and Technology Program (Nos. 2024NSFSC0537 and 2024NSFSC1759), 2024 Chongqing Young and middle-aged medical Talents Project (No. YXGD202438).

About International Journal of Oral Science

International Journal of Oral Science (ISSN 1674-2818) was founded in 2009 and aims to publish all aspects of oral science and interdisciplinary fields, including fundamental, applied and clinical research. Covered areas include oral microbiology, oral and maxillofacial oncology, cariology, oral inflammation and infection, dental stem cells and regenerative medicine, craniofacial surgery, dental materials, oral biomechanics, oral, dental and maxillofacial genetic and developmental diseases.

International Journal of Oral Science

Not applicable

A biomimetic nanoparticle coordinates antibacterial and immunomodulatory functions to promote periodontal regeneration

26-Oct-2026

The authors declare that they have no competing interests.

Keywords

Article Information

Contact Information

Yini Bao
West China School of Stomatology Sichuan University
ijos@scu.edu.cn

Source

This article is based on a news release from West China Hospital of Sichuan University. BrightSurf curates and republishes science news from research institutions worldwide; the original release is linked below.

How to Cite This Article

APA:
West China Hospital of Sichuan University. (2026, November 8). Biomimetic nanoparticle combines antibacterial and regenerative actions for periodontitis. Brightsurf News. https://www.brightsurf.com/news/8OMXWXZ1/biomimetic-nanoparticle-combines-antibacterial-and-regenerative-actions-for-periodontitis.html
MLA:
"Biomimetic nanoparticle combines antibacterial and regenerative actions for periodontitis." Brightsurf News, Nov. 8 2026, https://www.brightsurf.com/news/8OMXWXZ1/biomimetic-nanoparticle-combines-antibacterial-and-regenerative-actions-for-periodontitis.html.